Weil Company Inc. Cuts Holdings in Leidos Holdings, Inc. (NYSE:LDOS)

Weil Company Inc. reduced its holdings in Leidos Holdings, Inc. (NYSE:LDOS) by 10.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,700 shares of the aerospace company’s stock after selling 991 shares during the quarter. Weil Company Inc.’s holdings in Leidos were worth $1,269,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of LDOS. Key Financial Inc lifted its holdings in Leidos by 6.5% in the second quarter. Key Financial Inc now owns 1,141 shares of the aerospace company’s stock valued at $166,000 after acquiring an additional 70 shares during the period. Bleakley Financial Group LLC lifted its stake in shares of Leidos by 2.9% in the first quarter. Bleakley Financial Group LLC now owns 2,671 shares of the aerospace company’s stock valued at $350,000 after purchasing an additional 76 shares during the period. Somerset Trust Co boosted its holdings in Leidos by 4.7% during the second quarter. Somerset Trust Co now owns 2,346 shares of the aerospace company’s stock worth $342,000 after buying an additional 106 shares in the last quarter. UMB Bank n.a. grew its position in Leidos by 3.1% during the second quarter. UMB Bank n.a. now owns 3,569 shares of the aerospace company’s stock worth $521,000 after buying an additional 107 shares during the period. Finally, Czech National Bank grew its position in Leidos by 0.5% during the first quarter. Czech National Bank now owns 24,194 shares of the aerospace company’s stock worth $3,172,000 after buying an additional 111 shares during the period. 76.12% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

LDOS has been the topic of several research analyst reports. JPMorgan Chase & Co. boosted their price target on Leidos from $165.00 to $175.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 31st. Stifel Nicolaus boosted their target price on Leidos from $160.00 to $165.00 and gave the stock a “buy” rating in a research report on Monday, June 24th. Wells Fargo & Company upped their target price on Leidos from $168.00 to $172.00 and gave the company an “overweight” rating in a report on Thursday, August 1st. Barclays lifted their price target on Leidos from $160.00 to $165.00 and gave the stock an “overweight” rating in a research note on Monday, August 5th. Finally, TD Cowen increased their price objective on shares of Leidos from $155.00 to $166.00 and gave the company a “buy” rating in a research note on Wednesday, July 31st. Two research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $163.08.

Insider Activity

In other news, Director Gary Stephen May sold 1,000 shares of the company’s stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $144.02, for a total transaction of $144,020.00. Following the completion of the transaction, the director now owns 11,264 shares of the company’s stock, valued at approximately $1,622,241.28. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, Director Robert C. Kovarik, Jr. sold 1,059 shares of the stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $145.23, for a total value of $153,798.57. Following the transaction, the director now directly owns 7,455 shares of the company’s stock, valued at approximately $1,082,689.65. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Gary Stephen May sold 1,000 shares of the business’s stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $144.02, for a total value of $144,020.00. Following the sale, the director now directly owns 11,264 shares of the company’s stock, valued at approximately $1,622,241.28. The disclosure for this sale can be found here. Company insiders own 0.96% of the company’s stock.

Leidos Price Performance

NYSE:LDOS opened at $152.89 on Friday. Leidos Holdings, Inc. has a 12-month low of $89.22 and a 12-month high of $159.10. The firm has a market cap of $20.60 billion, a price-to-earnings ratio of 65.90, a price-to-earnings-growth ratio of 1.41 and a beta of 0.69. The company’s 50-day moving average is $149.72 and its two-hundred day moving average is $140.94. The company has a current ratio of 1.21, a quick ratio of 1.11 and a debt-to-equity ratio of 0.91.

Leidos (NYSE:LDOS) last announced its quarterly earnings data on Tuesday, July 30th. The aerospace company reported $2.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.36. The business had revenue of $4.13 billion for the quarter, compared to the consensus estimate of $4.06 billion. Leidos had a net margin of 2.72% and a return on equity of 28.40%. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.80 earnings per share. Research analysts expect that Leidos Holdings, Inc. will post 8.95 EPS for the current year.

Leidos Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 27th. Stockholders of record on Friday, September 13th will be given a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a dividend yield of 0.99%. The ex-dividend date of this dividend is Friday, September 13th. Leidos’s dividend payout ratio is currently 65.52%.

Leidos Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.